Gene Techno Science
VC Fund
Tokyo, Japan
Gene Techno Science is a VC fund in Tokyo focused on Medical and Health Care. Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan.The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer.Gene Techno Sciencewas founded in 2001 and is headquartered in Sapporo, Japan.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Gene Techno Science invests in
Stages Gene Techno Science invests in
Countries Gene Techno Science invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 2 (100%)
- Health Care 2 (100%)
- Beauty 1 (50%)
- Wellness 1 (50%)
- Biotechnology 1 (50%)
Stage
- Series B 1 (50%)
- Funding Round 1 (50%)
Country
- Japan 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Masaharu Tani
President & CEO
|
President & CEO | Total investments: 0 | Find email | |
Masayuki Kawakami
Corporate Officer, CTO
|
Corporate Officer, CTO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Heartseed
|
Heartseed is a biotechnology research firm that specializes in the development of purified ventricular cardiomyocytes derived from induced pluripotent stem cells for the treatment of heart failure. The company employs an innovative methodology that involves the creation of cardiomyocyte spheroids, small clusters of heart cells, using stem cells.These spheroids are then surgically implanted into the heart to improve its performance. | $26M / Series B / Nov 21, 2019 | |
ORTHOReBIRTH
|
ORTHOReBIRTH is a medical device sales and distribution company. The company produces and markets orthopedic biologics that improve patients' quality of life and offer superior outcomes. ORTHOReBIRTH U brings premium orthopedic biologics to surgeons practicing around the world. The company aims to decrease any burden, physically and mentallyof both patients and doctors by creating innovative medical apparatus in the field of orthopedics.ORTHOReBIRTH was founded in June 2011 and is headquartered in Georgetown, Texas. | $373K / Nov 10, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Gene Techno Science invest in?
Gene Techno Science invests primarily in Medical, Health Care and Beauty startups, most often at Series B and Funding Round stage. Most of the 2 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Gene Techno Science?
Public channels for Gene Techno Science include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Gene Techno Science?
The team at Gene Techno Science includes Masaharu Tani (President & CEO) and Masayuki Kawakami (Corporate Officer, CTO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
